KCM
BSX icon

Kornitzer Capital Management’s Boston Scientific BSX Stock Holding History

Kornitzer Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,537
Closed -$661K – 552
2026
Q1 		$661K Buy
10,537
+4,000
+61% +$320K 0.01% 439
2025
Q4 		$623K Sell
6,537
-2,600
-28% -$255K 0.01% 457
2025
Q3 		$892K Sell
9,137
-3,175
-26% -$329K 0.02% 411
2025
Q2 		$1.32M Hold
12,312
– – 0.03% 357
2025
Q1 		$1.24M Buy
12,312
+1,725
+16% +$174K 0.03% 350
2024
Q4 		$946K Hold
10,587
– – 0.02% 389
2024
Q3 		$887K Sell
10,587
-146,104
-93% -$11.5M 0.02% 398
2024
Q2 		$12.1M Buy
156,691
+125
+0.1% +$9.15K 0.23% 122
2024
Q1 		$10.7M Buy
156,566
+2,025
+1% +$130K 0.2% 160
2023
Q4 		$8.93M Sell
154,541
-171,475
-53% -$9.15M 0.17% 192
2023
Q3 		$17.2M Buy
326,016
+3,975
+1% +$208K 0.36% 68
2023
Q2 		$17.4M Sell
322,041
-7,423
-2% -$388K 0.34% 77
2023
Q1 		$16.5M Sell
329,464
-26,350
-7% -$1.24M 0.33% 87
2022
Q4 		$16.5M Sell
355,814
-45,000
-11% -$1.95M 0.33% 81
2022
Q3 		$15.5M Sell
400,814
-16,866
-4% -$677K 0.33% 81
2022
Q2 		$15.6M Sell
417,680
-125,170
-23% -$5.1M 0.31% 90
2022
Q1 		$24M Sell
542,850
-39,050
-7% -$1.69M 0.4% 72
2021
Q4 		$24.7M Sell
581,900
-225
-0% -$9.46K 0.37% 85
2021
Q3 		$25.3M Sell
582,125
-275
-0% -$12.2K 0.39% 77
2021
Q2 		$24.9M Sell
582,400
-250
-0% -$10.5K 0.37% 86
2021
Q1 		$22.5M Buy
582,650
+89,900
+18% +$3.4M 0.36% 93
2020
Q4 		$17.7M Buy
492,750
+169,290
+52% +$6.1M 0.3% 120
2020
Q3 		$12.4M Sell
323,460
-128,891
-28% -$4.97M 0.24% 148
2020
Q2 		$15.9M Buy
+452,351
New +$16.3M 0.32% 112

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Kornitzer Capital Management's BSX Position: Q2 2026 in Review

Kornitzer Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,537 shares — an estimated $661K sold.

Kornitzer Capital Management first reported a position in BSX in Q2 2020 and held it in 24 quarters. The position peaked at $25.3M in Q3 2021. 533 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kornitzer Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Kornitzer Capital Management sold 10,537 Boston Scientific shares in Q2 2026, an estimated $661K.
  • Kornitzer Capital Management first reported a position in Boston Scientific in Q2 2020 and held it in 24 quarters.
  • Kornitzer Capital Management's Boston Scientific position peaked at $25.3M in Q3 2021.
  • 533 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.